CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Genechip (CapitalBio, Beijing, China) is a system for diagnosing resistance to rifampin and isoniazid, which shows high efficiency in detecting drug-resistant tuberculosis. Here, we firstly evaluated ...
Donors for the Jennie Smoly Caruthers Biotechnology Building and for the CIMB program, gathered on May 9 to celebrate the placement of the building’s cornerstone. To commemorate the event, a time ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories ...
Affymetrix, Inc. (NASDAQ:AFFX) today launched the GeneChip(R) miRNA 2.0 Array. This enhanced version of its best-in-class microRNA (miRNA) interrogation solution will support the research community's ...
Affymetrix microarray-based gene-expression technology was used. ChipDX reports the discovery and validation of a genetic signature for early-stage colon cancer. The firm is developing an online ...
Abstract: Microarray experiments are affected by several sources of variability. The paper demonstrates the major role of the day-to-day variability, it underlines the importance of a randomized block ...
Protein signal pathway mapping of human breast cancer from I-SPY: Correlations with response and genomic subtyping. Background: The development of genomic signatures as predictive biomarkers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback